.Merck trumps earnings desires, raises purchases overview on sturdy requirement for best drugs like Keytruda CNBCMerck & Co. (MRK US) Defeats Earnings Estimates as Keytruda Purchases Growth BloombergMerck Stock: Pharma Giant Posts Sturdy End Results, However Overview Falls Short Real estate investor's Organization DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck defeats revenue and also purchases assumptions among Keytruda advantage, but provides combined full-year overview MarketWatch.